Tani, Soichiro
Tatli, Servet
Hata, Nobuhiko
Garcia-Rojas, Xavier
Olubiyi, Olutayo I.
Silverman, Stuart G.
Tokuda, Junichi
Funding for this research was provided by:
National Cancer Institute (R01CA138586)
Ministry of Education, Culture, Sports, Science, and Technology
National Institute of Biomedical Imaging and Bioengineering (P41EB015898)
National Institute of Biomedical Imaging and Bioengineering (R01EB020667)
Article History
Received: 10 February 2016
Accepted: 19 March 2016
First Online: 2 April 2016
Compliance with ethical standards
:
: The study protocol has been reviewed and approved by the institutional review board at Brigham and Women’s Hospital (IRB# 2002P001166), and was HIPAA compliant. Informed consent was waived by our institutional review board. NH has a financial interest in Harmonus, a company developing image-guided therapy products. NH’s interests were reviewed and are managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.